Amyloidsolution, acquisition of AI biotech company Deargen, speeding up the development of new drug for AD deargenplatform 6년 ago Amyloidsolution, acquisition of AI biotech company Deargen, speeding up the development of new drug for AD Lead More → 이 글 공유하기: X에 공유 (새 창에서 열림) X Facebook으로 공유하기 (새 창에서 열림) Facebook
